Abstract: The present invention includes a novel shapeable material or resin, specifically for dental use. It is an improvement over conventional dental resins because it is strong, safe, does not encourage the propagation of bacteria and contains no bisphenol A (BPA). Also, it is the preferred resiliency for use in the oral cavity.

Abstract: A radar apparatus for detecting a distance to an object by receiving an electromagnetic wave reflected by the object is disclosed. The radar apparatus comprises a scan part and an electromagnetic wave emitter. The scan part includes a polarized light separation member configured to pass a preset first component of the electromagnetic wave and reflect a preset second component of the electromagnetic wave. The first and second components, respectively, are polarized lights having first and second polarization directions, which are perpendicular to each other. The scan part scans the second component of the electromagnetic wave in a predetermine scan angle range by rotating the polarized light separation member around a predetermined rotation axis. The electromagnetic wave emitter emits the electromagnetic wave toward the polarized light separation member of the scan part.

Abstract: A head-up display apparatus allows an occupant of a vehicle to visually perceive a virtual image of an image light reflected by a windshield after passing through a cylindrical lens. The cylindrical lens is inclined against the image light to thereby reflect outside light not to reach an eye range of the occupant. The cylindrical lens is placed in a light guide portion such that (i) an action axis direction for an optical action and (ii) a horizontal direction in the display image agree with each other. Of the cylindrical lens, an inclination angle and installation depth are so set that light incident at an angle equal to or greater than an interception upper-limit incident angle and reflected by a pass-through side of the cylindrical lens does not arrive at the eye range of the occupant.

Abstract: An object of the present invention is to provide a monoclonal antibody which is useful for treating or diagnosing a disease relating to system ASC amino acid transporter 2 (hereinafter, referred to as “ASCT2”) or a method using the antibody. The present invention provides a monoclonal antibody which specifically recognizes a native three-dimensional structure of an extracellular region of ASCT2 and binds to the extracellular region, or an antibody fragment thereof; a hybridoma which produces the antibody; a DNA which encodes the antibody; a vector which contains the DNA; a transformant obtainable by introducing the vector; a process for producing an antibody or an antibody fragment thereof using the hybridoma or the transformant; and a therapeutic agent using the antibody or the antibody fragment thereof, and a diagnostic agent using the antibody or the antibody fragment thereof.

Abstract: A wireless blood glucose meter (2) has a blood glucose level detector (21), a transmitter (22), a receiver (23), a storage component (24), and a transmission power determiner (25). Whether or not an acknowledge signal has been received and the transmission power when the transmitter (22) has transmitted a blood glucose level are stored as history information in the storage component (24), and the transmission power determiner (25) determines the transmission power when the transmitter (22) transmits on the basis of the history information stored in the storage component (24).

Abstract: Medicaments for treating diseases related to HB-EGF escalation are in demand. The present invention provides a monoclonal antibody or an antibody fragment thereof which binds to a cell membrane-bound HB-EGF, a membrane type HB-EGF and a secretory HB-EGF.

Abstract: An interference filter assembly includes a condenser lens, a collimating lens, an interference filter, and an imaging device, which are arranged in a direction of light travel. The collimating lens is spaced from the condenser lens by a predetermined distance that corresponds to one of a focal length of the condenser lens and a focal length of the collimating lens. The collimating lens is provided by a single lens and applies a collimated light toward the imaging device through the interference filter in the direction of light travel. The collimating lens has a first surface adjacent to the condenser lens and a second surface adjacent to the interference filter. The first surface is a curved surface that is convex toward the condenser lens and a circular hyperboloid. The second surface is a plane surface and outputs the collimated light to the interference filter.

Abstract: A light ray controller has a circular frustum shape and is fitted in a circular hole of a top board such that its large diameter bottom opening faces upward. The light ray controller transmits a light ray while diffusing the light ray in a ridgeline direction and transmits the light ray straightforward without diffusing the light ray in a circumferential direction. A rotation module is provided under the table. One or more scanning projectors are provided on a circumference around an axis of the light ray controller on the rotation base of the rotation module. One or more scanning projectors are rotated by the rotation module. The controller controls one or more scanning projectors being rotated based on three-dimensional shape data stored in a storage.

Abstract: Medicaments for treating diseases related to HB-EGF escalation are in demand. The present invention provides a monoclonal antibody or an antibody fragment thereof which binds to a cell membrane-bound HB-EGF, a membrane type HB-EGF and a secretory HB-EGF.

Abstract: Medicaments for treating diseases related to HB-EGF escalation are in demand. The present invention provides a monoclonal antibody or an antibody fragment thereof which binds to a cell membrane-bound HB-EGF, a membrane type HB-EGF and a secretory HB-EGF.

Abstract: Disclosed is a technology of discharging, from a drug cartridge, a drug instructed to discharge, while managing a plurality of drugs stored in a drug cartridge. The technology makes it possible to correctly discharge the drugs even when the dosing order of the drugs is changed. A medical agent dispenser has: a main body case (1); an annular drug cartridge (2) which is housed in the main body case (1) and has a plurality of holders (3) at equal intervals in the longitudinal direction; a discharge mechanism (7) which discharges the drugs from the holders (3); and an input interface (6) which receives operations of leading the drug to be discharged. Based on the number of operations the input interface (6) has received, gears (4a, 4b), i.e., rotating mechanisms which rotationally transfer the drug cartridge (2), are controlled.

Abstract: An object of the present invention is to provide a monoclonal antibody which is useful as a diagnostic agent or a therapeutic agent for a disease relating to a polypeptide encoded by Claudin-4 (hereinafter referred to as “CLDN4”) gene or a polypeptide encoded by a Claudin-3 (hereinafter referred to as “CLDN3”) gene, or a method for using the same.

Abstract: A drive voltage supply circuit has a first wire line, a second wire line, a first drive circuit, a plurality of second drive circuits, a control circuit for driving the first drive circuit and the plurality of second drive circuits, and an impedance element connected between the first wire line and each of output terminals.

Abstract: The present invention includes a novel shapeable material or resin, specifically for dental use. It is an improvement over conventional dental resins because it is strong, safe, does not encourage the propagation of bacteria and contains no bisphenol A (BPA). Also, it is the preferred resiliency for use in the oral cavity.

Abstract: On a semiconductor chip in a semiconductor integrated circuit, a plurality of circuit cells each of which has a pad are formed along a first chip side of the semiconductor chip. Among the plurality of circuit cells, one or more circuit cells at least in the vicinity of an end portion on the first chip side are arranged having a steplike shift in a direction apart from the first chip side with decreasing distance from the center portion to the end portion on the first chip side.

Abstract: Disclosed are a curable composition characterized by using a curable composition including an organic polymer (A1) having one or more silicon-containing functional groups capable of cross-linking by forming siloxane bonds in which the one or more silicon-containing functional groups capable of cross-linking by forming siloxane bonds are silicon-containing functional groups each having three or more hydrolyzable groups on one or more silicon atoms thereof; and a method for controlling the recovery properties, durability and creep resistance of the cured article. Herewith, the present invention provides a curable composition capable of giving a cured article excellent in recovery properties, durability and creep resistance, and a method for controlling the recovery properties, durability and creep resistance of the cured article.

Abstract: The collector, emitter, and base of a bipolar transistor circuit are connected to a high side power supply terminal, the drain of a level shift transistor, and a floating power supply terminal, respectively. When a high side output transistor is on, the floating power supply terminal is at the potential of a high potential power supply terminal. The high side power supply terminal is at a potential higher than the potential of the floating power supply terminal by a constant voltage. Turning the level shift transistor on, its drain potential drops below the potential of the floating power supply terminal; The base current flows through the bipolar transistor circuit and the drain potential of the level shift transistor is clamped near the potential of the floating power supply terminal; The bipolar transistor circuit is turned on and its collector current supplies the drain current of the level shift transistor.

Abstract: Disclosed are a curable composition characterized by using a curable composition including an organic polymer (A1) having one or more silicon-containing functional groups capable of cross-linking by forming siloxane bonds in which the one or more silicon-containing functional groups capable of cross-linking by forming siloxane bonds are silicon-containing functional groups each having three or more hydrolyzable groups on one or more silicon atoms thereof; and a method for controlling the recovery properties, durability and creep resistance of the cured article. Herewith, the present invention provides a curable composition capable of giving a cured article excellent in recovery properties, durability and creep resistance, and a method for controlling the recovery properties, durability and creep resistance of the cured article.

Abstract: Medicaments for treating diseases related to HB-EGF escalation are in demand. The present invention provides a monoclonal antibody or an antibody fragment thereof which binds to a cell membrane-bound HB-EGF, a membrane type HB-EGF and a secretory HB-EGF.

Abstract: Medicaments for treating diseases related to HB-EGF escalation are in demand. The present invention provides a monoclonal antibody or an antibody fragment thereof which binds to a cell membrane-bound HB-EGF, a membrane type HB-EGF and a secretory HB-EGF.